BANK OF AMERICA CORP /DE/
BankPosition in SNDX — Syndax Pharmaceuticals Inc
CIK 70858
CHARLOTTE, NC
Position in SNDX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$88,425,753
-$10,850,415 QoQ
Shares Held
4,045,094
-4.8% QoQ
Ownership
4.53%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#5
of 242 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 65%
Shared 0%
None 35%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Derivatives in SNDX
reported options exposure · as of Sep 30, 2024CallValue
$2,021,250
CallShares
105,000
PutValue
$1,347,500
PutShares
70,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. SNDX ranks #27 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in SNDX
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $88,425,753 | 4,045,094 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $99,276,168 | 4,249,836 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $98,972,771 | 4,710,746 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $56,889,929 | 3,697,753 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $35,951,035 | 3,838,872 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $35,270,222 | 2,870,999 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,245,614 | 245,508 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,347,500 | 70,000 | Put | Defined | 2024-11-14 | |
| 2024-09-30 | $14,578,158 | 757,307 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $2,021,250 | 105,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $17,495,787 | 852,206 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,390,235 | 1,655,052 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,111,840 | 144,000 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $21,269,812 | 984,258 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $635,976 | 43,800 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $3,773,136 | 259,858 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $5,941,334 | 283,867 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,056,000 | 50,000 | Put | Defined | 2023-05-12 | |
| 2023-03-31 | $8,345,967 | 395,169 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,813,268 | 267,712 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $7,260,135 | 302,128 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,455,197 | 75,634 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,975,322 | 113,655 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $4,135,829 | 188,937 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $1,723,281 | 90,177 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $563,811 | 32,837 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $2,305,561 | 103,111 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,036,983 | 46,627 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $378,239 | 25,626 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $679,081 | 45,822 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $295,081 | 26,899 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||